Roche enters $1.15 bln licensing deal for Sarepta gene therapy [Reuters]
Sarepta Therapeutics, Inc. (SRPT)
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investorrelations.sarepta.com/events-and-presentations
Company Research
Source: Reuters
Roche enters $1.15 billion licensing deal for Sarepta gene therapy ZURICH (Reuters) - Roche ( ROG.S ) entered into a $1.15 billion licensing agreement with Sarepta Therapeutics ( SRPT.O ) to obtain the right to launch and commercialize Sarepta’s gene therapy for Duchenne muscular dystrophy (DMD) outside the United States, it said on Monday. Roche will make an upfront payment of $750 million in cash and $400 million worth in equity at closing for Sarepta’s investigational micro-dystrophin gene therapy SRP-9001, it said in a statement on Monday. Sarepta is eligible to receive up to $1.7 billion in regulatory and sales milestones, plus royalties on net sales, Roche said.
Show less
Read more
Impact Snapshot
Event Time:
SRPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRPT alerts
High impacting Sarepta Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SRPT
News
- Exploring 3 High Growth Tech Stocks in United States [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks To Watch For Potential Investment [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks To Explore In November 2024 [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks Featuring ALSO Holding And 2 More [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks To Watch In The Current Market [Yahoo! Finance]Yahoo! Finance
SRPT
Earnings
- 11/6/24 - Beat
SRPT
Sec Filings
- 11/14/24 - Form SC
- 11/13/24 - Form SC
- 11/6/24 - Form 10-Q
- SRPT's page on the SEC website